Literature DB >> 33665206

E2F1: Cause and Consequence of DNA Replication Stress.

Shahd Fouad1, David Hauton1, Vincenzo D'Angiolella1.   

Abstract

In mammalian cells, cell cycle entry occurs in response to the correct stimuli and is promoted by the transcriptional activity of E2F family members. E2F proteins regulate the transcription of S phase cyclins and genes required for DNA replication, DNA repair, and apoptosis. The activity of E2F1, the archetypal and most heavily studied E2F family member, is tightly controlled by the DNA damage checkpoints to modulate cell cycle progression and initiate programmed cell death, when required. Altered tumor suppressor and oncogenic signaling pathways often result in direct or indirect interference with E2F1 regulation to ensure higher rates of cell proliferation independently of external cues. Despite a clear link between dysregulated E2F1 activity and cancer progression, literature on the contribution of E2F1 to DNA replication stress phenotypes is somewhat scarce. This review discusses how dysfunctional tumor suppressor and oncogenic signaling pathways promote the disruption of E2F1 transcription and hence of its transcriptional targets, and how such events have the potential to drive DNA replication stress. In addition to the involvement of E2F1 upstream of DNA replication stress, this manuscript also considers the role of E2F1 as a downstream effector of the response to this type of cellular stress. Lastly, the review introduces some reflections on how E2F1 activity is integrated with checkpoint control through post-translational regulation, and proposes an exploitable tumor weakness based on this axis.
Copyright © 2021 Fouad, Hauton and D'Angiolella.

Entities:  

Keywords:  DNA replication stress; E2F1; cyclin E; cyclin F; retinoblastoma; ribonucleotide reductase; ubiquitin proteasome system

Year:  2021        PMID: 33665206      PMCID: PMC7921158          DOI: 10.3389/fmolb.2020.599332

Source DB:  PubMed          Journal:  Front Mol Biosci        ISSN: 2296-889X


  105 in total

Review 1.  Principles for the buffering of genetic variation.

Authors:  J L Hartman; B Garvik; L Hartwell
Journal:  Science       Date:  2001-02-09       Impact factor: 47.728

2.  S Phase-specific transcription of the mouse ribonucleotide reductase R2 gene requires both a proximal repressive E2F-binding site and an upstream promoter activating region.

Authors:  Anna Lena Chabes; Stefan Björklund; Lars Thelander
Journal:  J Biol Chem       Date:  2003-12-19       Impact factor: 5.157

Review 3.  Maintaining genome stability at the replication fork.

Authors:  Dana Branzei; Marco Foiani
Journal:  Nat Rev Mol Cell Biol       Date:  2010-03       Impact factor: 94.444

4.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.

Authors:  Jirina Bartkova; Zuzana Horejsí; Karen Koed; Alwin Krämer; Frederic Tort; Karsten Zieger; Per Guldberg; Maxwell Sehested; Jahn M Nesland; Claudia Lukas; Torben Ørntoft; Jiri Lukas; Jiri Bartek
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

5.  HDM-2 inhibition suppresses expression of ribonucleotide reductase subunit M2, and synergistically enhances gemcitabine-induced cytotoxicity in mantle cell lymphoma.

Authors:  Richard J Jones; Veerabhadran Baladandayuthapani; Sattva Neelapu; Luis E Fayad; Jorge E Romaguera; Michael Wang; Rakesh Sharma; Dajun Yang; Robert Z Orlowski
Journal:  Blood       Date:  2011-08-15       Impact factor: 22.113

6.  Nucleotide deficiency promotes genomic instability in early stages of cancer development.

Authors:  Assaf C Bester; Maayan Roniger; Yifat S Oren; Michael M Im; Dan Sarni; Malka Chaoat; Aaron Bensimon; Gideon Zamir; Donna S Shewach; Batsheva Kerem
Journal:  Cell       Date:  2011-04-29       Impact factor: 41.582

Review 7.  E2F1 apoptosis counterattacked: evil strikes back.

Authors:  Brigitte M Pützer; David Engelmann
Journal:  Trends Mol Med       Date:  2012-12-05       Impact factor: 11.951

8.  Expression of nucleoside transporters, deoxycitidine kinase, ribonucleotide reductase regulatory subunits, and gemcitabine catabolic enzymes in primary ovarian cancer.

Authors:  Gabriella Ferrandina; Valentina Mey; Sara Nannizzi; Simona Ricciardi; Marco Petrillo; Cristiano Ferlini; Romano Danesi; Giovanni Scambia; Mario Del Tacca
Journal:  Cancer Chemother Pharmacol       Date:  2009-07-29       Impact factor: 3.333

Review 9.  Quality control in the initiation of eukaryotic DNA replication.

Authors:  John F X Diffley
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-12-27       Impact factor: 6.237

10.  Myc and Ras oncogenes engage different energy metabolism programs and evoke distinct patterns of oxidative and DNA replication stress.

Authors:  Apolinar Maya-Mendoza; Jitka Ostrakova; Martin Kosar; Arnaldur Hall; Pavlina Duskova; Martin Mistrik; Joanna Maria Merchut-Maya; Zdenek Hodny; Jirina Bartkova; Claus Christensen; Jiri Bartek
Journal:  Mol Oncol       Date:  2014-11-15       Impact factor: 6.603

View more
  6 in total

1.  E2F1 Expression and Apoptosis Initiation in Crayfish and Rat Peripheral Neurons and Glial Cells after Axonal Injury.

Authors:  Valentina Dzreyan; Moez Eid; Stanislav Rodkin; Maria Pitinova; Svetlana Demyanenko
Journal:  Int J Mol Sci       Date:  2022-04-18       Impact factor: 6.208

2.  Positive regulation of ataxia-telangiectasia-mutated protein (ATM) by E2F transcription Factor 1 (E2F-1) in cisplatin-resistant nasopharyngeal carcinoma cells.

Authors:  Zun-Yan Zhou; Ji-Yuan Yang; Cheng-Ze Shao; Fei Luo; Wei Du
Journal:  World J Surg Oncol       Date:  2022-03-18       Impact factor: 2.754

3.  Bioinformatic-based mechanism identification of E2F1-related ceRNA and E2F1 immunoassays in hepatocellular carcinoma.

Authors:  Wenlei Dong; Chao Zhan
Journal:  J Gastrointest Oncol       Date:  2022-08

Review 4.  The Epigenetic Regulation of Nonhistone Proteins by SETD7: New Targets in Cancer.

Authors:  Chengyao Chiang; Heng Yang; Lizhi Zhu; Chunlan Chen; Cheng Chen; You Zuo; Duo Zheng
Journal:  Front Genet       Date:  2022-06-22       Impact factor: 4.772

5.  Targeting E2F Sensitizes Prostate Cancer Cells to Drug-Induced Replication Stress by Promoting Unscheduled CDK1 Activity.

Authors:  Mohaddase Hamidi; Ainhoa Eriz; Jone Mitxelena; Larraitz Fernandez-Ares; Igor Aurrekoetxea; Patricia Aspichueta; Ainhoa Iglesias-Ara; Ana M Zubiaga
Journal:  Cancers (Basel)       Date:  2022-10-10       Impact factor: 6.575

6.  E2F transcription factor 1 is involved in the phenotypic modulation of esophageal squamous cell carcinoma cells via microRNA-375.

Authors:  Pengfei Li; Huina Lv; Yongkai Wu; Ke Xu; Min Xu; Yegang Ma
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.